foslevodopa; levodopa phosphate
Jump to navigation
Jump to search
Indications
- component of foscarbidopa/foslevodopa
More general terms
Component of
References
- ↑ Rosebraugh M et al. Foslevodopa/foscarbidopa: A new subcutaneous treatment for Parkinson's disease. Ann Neurol 2021 Mar 26; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33772855 https://onlinelibrary.wiley.com/doi/10.1002/ana.26073